<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: An increase in the production of reactive oxygen species is commonly thought to contribute to the development of diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to assess whether administration of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="1" ids="23354">coenzyme</z:chebi> Q(10) would protect the diabetic heart against dysfunction and remodelling, using the db/db mouse model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, we aimed to compare the efficacy of <z:chebi fb="1" ids="23354">coenzyme</z:chebi> Q(10) to that of the <z:chebi fb="2" ids="35457">ACE inhibitor</z:chebi> <z:chebi fb="0" ids="8774">ramipril</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Six-week-old non-diabetic db/+ mice and diabetic db/db mice received either <z:mpath ids='MPATH_458'>normal</z:mpath> drinking water or water supplemented with <z:chebi fb="1" ids="23354">coenzyme</z:chebi> Q(10) for 10 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>Endpoint cardiac function was assessed by echocardiography and catheterisation </plain></SENT>
<SENT sid="5" pm="."><plain>Ventricular tissue was collected for histology, gene expression and protein analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Untreated db/db diabetic mice exhibited <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e>, accompanied by diastolic dysfunction and adverse structural remodelling, including cardiomyocyte <z:mpath ids='MPATH_159'>hypertrophy</z:mpath>, <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> and <z:mp ids='MP_0006042'>increased apoptosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Systemic <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and myocardial <z:chebi fb="1" ids="18421">superoxide</z:chebi> generation were also elevated in db/db mice </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="1" ids="23354">Coenzyme</z:chebi> Q(10) and <z:chebi fb="0" ids="8774">ramipril</z:chebi> treatment reduced <z:chebi fb="1" ids="18421">superoxide</z:chebi> generation, ameliorated diastolic dysfunction and reduced cardiomyocyte <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and <z:mp ids='MP_0003045'>fibrosis</z:mp> in db/db mice </plain></SENT>
<SENT sid="9" pm="."><plain>Phosphorylation of Akt, although depressed in untreated db/db mice, was restored with <z:chebi fb="1" ids="23354">coenzyme</z:chebi> Q(10) administration </plain></SENT>
<SENT sid="10" pm="."><plain>We postulate that preservation of cardioprotective Akt signalling may be a mechanism by which <z:chebi fb="1" ids="23354">coenzyme</z:chebi> Q(10)-treated db/db mice are protected from pathological <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: These data demonstrate that <z:chebi fb="1" ids="23354">coenzyme</z:chebi> Q(10) attenuates <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:e sem="disease" ids="C1273070" disease_type="Disease or Syndrome" abbrv="">left ventricular diastolic dysfunction</z:e> and remodelling in the diabetic heart </plain></SENT>
<SENT sid="12" pm="."><plain>Addition of <z:chebi fb="1" ids="23354">coenzyme</z:chebi> Q(10) to the current therapy used in diabetic patients with diastolic dysfunction warrants further investigation </plain></SENT>
</text></document>